Suchergebnisse - "Ritonavir"

PubPharm (411)

1

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents : a substudy of the SMILE trial

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Abdalla, S. | Compagnucci, A. | Riault, Y. | +14

2

Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors : blockage of its enzymatic activity and interference with fungal growth and macrophage interaction

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2020

von Granato, M. | Sousa, I. | Rosa, T. | +6

3

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy

enthalten in: Antimicrobial agents and chemotherapy | 2020

von Eke, A. | Wang, J. | Amin, K. | +46

4

Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Feng, H. | Caro, L. | Fandozzi, C. | +21

5

Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics

enthalten in: European journal of clinical pharmacology | 2018

von Freise, K. | Hu, B. | Salem, A.

6

Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain

enthalten in: Journal of medical virology | 2016

von Pernas, B. | Grandal, M. | Tabernilla, A. | +7

7

Severe Hyperbilirubinemia in an HIV-HCV-Coinfected Patient Starting the 3D Regimen That Resolved After TDM-Guided Atazanavir Dose Reduction

enthalten in: Therapeutic drug monitoring | 2016

von Cattaneo, D. | Riva, A. | Clementi, E. | +2

8

Economic and Public Health Impacts of Policies Restricting Access to Hepatitis C Treatment for Medicaid Patients

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2016

von Chidi, A. | Bryce, C. | Donohue, J. | +7

9

Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2016

von Khatri, A. | Dutta, S. | Wang, H. | +4

CommentIn: Clin Infect Dis. 2016 Jul 15;63(2):285-6. - PMID 27143665

10

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients : A Randomized, Multinational, Multicenter Trial

enthalten in: PloS one | 2016

von Cooper, D. | Cordery, D. | Zajdenverg, R. | +87

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[42]